Trial Profile
Clinical Trials Insight: 700008629
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2007
Price :
$35
*
At a glance
- Drugs Ozarelix (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 05 Sep 2007 Interim results have been reported.
- 22 Nov 2005 New trial record.